Market Overview:
The Global Cardiovascular Information System Market was valued at USD 665.27 million in 2016 and is projected to reach USD 1,269.09 million by 2025, growing at a CAGR of 7.4% from 2017 to 2025.
The software provides every facilitys cardiology department, regardless of its size or scope, faces similar challenges in. Lost time from inefficient workflow, shrinking reimbursements despite increasing costs and mounting pressure to improve quality of care are having a significant impact on business performance and care outcomes. This Technology provides the key to improving performance.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing chances of cases of cardiovascular disaeases
1.2 Focus on Operational efficiency and reduce medical errors
1.3 Need to curtail Healthcare cost
2. Market Restraints
2.1 High Implementation cost
2.2 Resistance in Medical Service providers
Market Segmentation:
The Cardiovascular Information System Market is segmented on the basis of product, extraction method, application, and region.
1. Global Cardiovascular Information System Market, by Component:
1.1 Software
1.2 Services
1.3 Hardware
2. Global Cardiovascular Information System Market, by End User:
2.1 Hospitals
2.1.1 Small sized
2.1.2 Medium Sized
2.1.3 Large Sized
2.2 Diagnostic Centres
3. Global Cardiovascular Information System Market, by Type:
3.1 Software
3.2 Services
3.3 Hardware
4. Global Cardiovascular Information System Market, by system Type:
4.1 CVIS
4.2 CPACS
5. Global Cardiovascular Information System Market, by Mode of Operations:
5.1 Web based
5.2 Onsite
5.3 Cloud-based
6. Global Cardiovascular Information System Market, By Application:
6.1 Catheterization Lab CVIS Solutions
6.2 Echocardiography Lab CVIS Solutions
6.3 Electrophysiology Lab CVIS Solutions
6.4 Nuclear Cardiology CVIS Solutions
6.5 Cardiothoracic Center CVIS Solutions
6.6 Ecg/Holter Monitoring CVIS Solutions
6.7 Pacemaker/ICD Lab CVIS Solutions
6.8 Heart Failure Center CVIS Solutions
6.9 Outpatient Clinic CVIS Solutions
6.10 Other Applications
7. Global Cardiovascular Information System Market, by Region:
7.1 North America (U.S., Canada, Mexico)
7.2 Europe (Germany, UK, France, Rest of Europe)
7.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
7.4 Latin America (Brazil, Argentina, Rest of Latin America)
7.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Philips Healthcare (A Subsidiary of Royal Philips Electronics)
2. Mckesson Corporation
3. Ge Healthcare (A Subsidiary of General Electric Company)
4. Siemens Healthcare (A Subsidiary of Siemens AG Company)
5. Merge Healthcare
6. AGFA Healthcare
7. Lumedx
8. Digisonics
9. Fujifilm Medical Systems
10. Cerner Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on The Cardiovascular Information System Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT
5.1 Software
5.2 Services
5.3 Hardware
6 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER
6.1 Hospitals
6.1.1 Small sized
6.1.2 Medium Sized
6.1.3 Large Sized
6.2 Diagnostic Centres
7 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY TYPE
7.1 Software
7.2 Services
7.3 Hardware
8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY SYSTEM TYPE
8.1 CVIS
8.2 CPACS
9 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY MODE OF OPERATIONS
9.1 Web based
9.2 Onsite
9.3 Cloud-based
10 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION
10.1 Catheterization Lab CVIS Solutions
10.2 Echocardiography Lab CVIS Solutions
10.3 Electrophysiology Lab CVIS Solutions
10.4 Nuclear Cardiology CVIS Solutions
10.5 Cardiothoracic Center CVIS Solutions
10.6 Ecg/Holter Monitoring CVIS Solutions
10.7 Pacemaker/ICD Lab CVIS Solutions
10.8 Heart Failure Center CVIS Solutions
10.9 Outpatient Clinic CVIS Solutions
11 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY GEOGRAPHY
11.1 Overview
11.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
11.2.1 U.S.
11.2.2 Canada
11.2.3 Mexico
11.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
11.5.1 Brazil
11.5.2 Argentina
11.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
12 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET COMPETITIVE LANDSCAPE
12.1 Overview
12.2 Company Market Share
12.3 Vendor Landscape
12.4 Key Development Strategies
13 COMPANY PROFILES
13.1 Philips Healthcare
13.1.1 Overview
13.1.2 Financial Performance
13.1.3 Product Outlook
13.1.4 Key Developments
13.2 Mckesson Corporation
13.2.1 Overview
13.2.2 Financial Performance
13.2.3 Product Outlook
13.2.4 Key Developments
13.3 GE Healthcare
13.3.1 Overview
13.3.2 Financial Performance
13.3.3 Product Outlook
13.3.4 Key Developments
13.4 Siemens Healthcare
13.4.1 Overview
13.4.2 Financial Performance
13.4.3 Product Outlook
13.4.4 Key Developments
13.5 Merge Healthcare
13.5.1 Overview
13.5.2 Financial Performance
13.5.3 Product Outlook
13.5.4 Key Developments
13.6 AGFA Healthcare
13.6.1 Overview
13.6.2 Financial Performance
13.6.3 Product Outlook
13.6.4 Key Developments
13.7 Lumedx
13.7.1 Overview
13.7.2 Financial Performance
13.7.3 Product Outlook
13.7.4 Key Developments
13.8 Digisonics
13.8.1 Overview
13.8.2 Financial Performance
13.8.3 Product Outlook
13.8.4 Key Developments
13.9 Fujifilm Medical Systems
13.9.1 Overview
13.9.2 Financial Performance
13.9.3 Product Outlook
13.9.4 Key Developments
13.10 Cerner Corporation
13.10.1 Overview
13.10.2 Financial Performance
13.10.3 Product Outlook
13.10.4 Key Developments
14 Appendix
14.1 Related Reports